Anticancer effects of miR-124 delivered by BM-MSC derived exosomes on cell proliferation, epithelial mesenchymal transition, and chemotherapy sensitivity of pancreatic cancer cells.

Xu, Yan; Liu, Nanbin; Wei, Yuhua; Zhou, Deren; Lin, Rui; Wang, Xiuyan; Shi, Baomin

Xu, Yan; Liu, Nanbin; Wei, Yuhua; Zhou, Deren; Lin, Rui; Wang, Xiuyan; Shi, Baomin.

Afiliación

Xu Y; Department of General Surgery, Tongji Hospital, Tongji University Medical School, Shanghai 200065, China.
Liu N; Department of General Surgery, Tongji Hospital, Tongji University Medical School, Shanghai 200065, China.
Wei Y; Department of General Surgery, Tongji Hospital, Tongji University Medical School, Shanghai 200065, China.
Zhou D; Department of General Surgery, Tongji Hospital, Tongji University Medical School, Shanghai 200065, China.
Lin R; Department of General Surgery, Tongji Hospital, Tongji University Medical School, Shanghai 200065, China.
Wang X; Department of Ultrasonography, Tongji Hospital, Tongji University Medical School, Shanghai 200065, China.
Shi B; Department of General Surgery, Tongji Hospital, Tongji University Medical School, Shanghai 200065, China.

Aging (Albany NY) ; 12(19): 19660-19676, 2020 Oct 11.

Article en En | MEDLINE | ID: mdl-33040049

Palabras clave

BM-MSCs; cancer; chemotherapy sensitivity; epithelial mesenchymal transition; miR-124

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Aging (Albany NY) Asunto de la revista: GERIATRIA Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google